The paper's citation list
No.The paper's citation list
1Mechanisms of Multidrug Resistance in Cancer Chemotherapy. 2020;21:3233 doi: 10.3390/ijms21093233
2Phytochemicals: Potential Lead Molecules for MDR Reversal. 2020;11: doi: 10.3389/fphar.2020.00832
3Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells. 2020;12:2482 doi: 10.3390/cancers12092482
4Resveratrol in Cancer Patients: From Bench to Bedside. 2020;21:2945 doi: 10.3390/ijms21082945
5Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity. 2020;12:1576 doi: 10.3390/cancers12061576
6CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials. 2020;11:921 doi: 10.3390/genes11080921
7Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line. 2020;148:105315 doi: 10.1016/j.ejps.2020.105315
8β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance. 2020;21:4210 doi: 10.3390/ijms21124210
9Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma. 2020;12:2518 doi: 10.3390/cancers12092518
10Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. 2020;25:3364 doi: 10.3390/molecules25153364
11In vitro phototherapeutic effects of indolenine-based mono- and dithiosquaraine cyanine dyes against Caco-2 and HepG2 human cancer cell lines. 2020;31:101844 doi: 10.1016/j.pdpdt.2020.101844
12Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer. 2020;12:524 doi: 10.3390/pharmaceutics12060524